Schizophrenia Research Compounds
It has been hypothesized that excess dopamine in mesolimbic neurons may be involved in the positive symptoms of schizophrenia. It has also been hypothesized that serotonergic predominance in the mesocortical system due to an imbalance between the serotonergic system, which suppresses the dopaminergic system, and the dopaminergic system may be involved in the negative symptoms of schizophrenia; many factors, including serotonin and dopamine, have been studied.
FUJIFILM Wako has made a variety of compounds available, including serotonin and dopamine receptor blockers.
- Open All
- Close All
Serotonin/Dopamine Receptor Blockers
Multi-acting Receptor Blocker
Dopamine Receptor Agonist/Antagonist
Dopamine D2 Receptor Blockers
Compounds for Generating Animal Model of Schizophrenia
Cannabinoid Receptor-related Compounds
For research use or further manufacturing use only. Not for use in diagnostic procedures.
Product content may differ from the actual image due to minor specification changes etc.
If the revision of product standards and packaging standards has been made, there is a case where the actual product specifications and images are different.